Novel use of adenoviruses and nucleic acids coding therefor

Details for Australian Patent Application No. 2010219364 (hide)

Owner Holm, P.

Inventors Holm, Per Sonne

Agent Pizzeys

Pub. Number AU-B-2010219364

Parent 2003242585

Filing date 9 September 2010

Wipo publication date 30 September 2010

Acceptance publication date 9 June 2011

International Classifications

C12N 15/861 (2006.01) Mutation or genetic engineering - Adenoviral vectors

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61P 35/00 (2006.01) Antineoplastic agents

C07K 14/075 (2006.01) Peptides having more than 20 amino acids

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

23 September 2010 Complete Application Filed

30 September 2010 Application Open to Public Inspection

  Published as AU-B-2010219364

9 June 2011 Application Accepted

  Published as AU-B-2010219364

6 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010219365-A Bracket, System Including Same and Method of Use

2010219363-Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof